Quick Answer
Edwards Lifesciences Corp reported Shares Outstanding of 580.70 million shares for fiscal year 2025.
Edwards Lifesciences Corp Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 580.70M | -1.3% |
| 2024 | 588.60M | -2.1% |
| 2023 | 601.10M | -1.2% |
| 2022 | 608.30M | -2.5% |
| 2021 | 624.10M | -0.0% |
| 2020 | 624.30M | +198.6% |
| 2019 | 209.10M | +0.7% |
| 2018 | 207.70M | -1.0% |
| 2017 | 209.70M | -0.9% |
| 2016 | 211.60M | -1.8% |
| 2015 | 215.40M | +99.8% |
| 2014 | 107.80M | -1.4% |
| 2013 | 109.30M | -4.4% |
| 2012 | 114.30M | +0.2% |
| 2011 | 114.10M | -0.8% |
| 2010 | 115.00M | +102.5% |
| 2009 | 56.80M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 580.70M | -1.5% | -1.2% |
| June 30, 2025 | 587.90M | -2.4% | +0.3% |
| March 31, 2025 | 586.20M | -2.7% | -0.4% |
| December 31, 2024 | 588.60M | -2.1% | -0.2% |
| September 30, 2024 | 589.80M | -2.8% | -2.1% |
| June 30, 2024 | 602.30M | -0.9% | -0.0% |
| March 31, 2024 | 602.40M | -0.6% | +0.2% |
| December 31, 2023 | 601.10M | -1.2% | -0.9% |
- Edwards Lifesciences Corp showed a decrease of -1.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2009–2025 period, Edwards Lifesciences Corp’s shares outstanding has grown by 922.4% (from 56.80 million shares to 580.70 million shares).
- The most recent figure is from Edwards Lifesciences Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: